13 High Growth International Stocks to Buy Right Now
On September 12, CNBC reported that according to data released the same day, the UK economy recorded zero growth in July after expanding by 0.4% in June.
Biontech Se (BNTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 368,923 | $39,279,232 | +720% | 0.38% |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 335,660 | $35,737,720 | -4% | 0.04% |
| 3. | Tang Capital Management Kevin C. Tang | 270,000 | $28,746,900 | 1.45% | |
| 4. | Long Focus Capital Management John B. Helmers | 207,903 | $22,135,432 | +31% | 0.84% |
| 5. | 170,800 | $18,185,076 | -25% | 0% |
Institutional Investors' Holdings
News See All
Bristol Myers Squibb, BioNTech Announce Positive Interim Data from Phase 2 Trial of Pumitamig in Lung Cancer
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best inexpensive stocks to buy according to hedge funds.
BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal
BioNTech SE (NASDAQ:BNTX), a German biotechnology company, specializes in mRNA-based immunotherapies for cancer and infectious diseases and stands eleventh on our list among the best cancer stocks.
11 Best Cancer Stocks to Buy Right Now
Cancer remains the second leading cause of death globally, after heart disease.
BioNTech SE (NASDAQ:BNTX) Q2 2025 Earnings Call Transcript
Douglas Maffei: Thank you, operator. Good morning and good afternoon. Thank you for joining BioNTech's Second Quarter 2025 Earnings Call.
Recent Agreements Set To Bolster BioNTech SE (BNTX)'s Oncology Arm
On June 2, the company announced that it had agreed with Bristol Myers Squibb for the global joint development and commercialization of BioNTech SE (NASDAQ:BNTX)’s investigational bispecific antibody...
13 Best German Stocks to Invest in Now
However, on a year-to-date basis, the DAX index has gained 19.48%, comfortably outperforming its US counterparts, driven by a robust show by the country’s defense stocks, as European governments unlocked...
Truist Lifts BioNTech (BNTX) Price Target After New Partnership
This decision came after the company entered into an agreement with Bristol Myers Squibb for the co-development and co-commercialization of BioNTech SE’s (NASDAQ:BNTX) investigational bispecific antibody...
Why BioNTech SE (BNTX) Skyrocketed On Monday
We recently published a list of These 10 Stocks Blew Past Expectations.
Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies
Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the global biopharmaceutical market.